Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

7.08
Delayed Data
As of Apr 29
 -0.21 / -2.88%
Today’s Change
5.02
Today|||52-Week Range
13.26
-10.38%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Merrimack Pharmaceuticals Inc have a median target of 14.00, with a high estimate of 16.00 and a low estimate of 11.00. The median estimate represents a +97.74% increase from the last price of 7.08.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Merrimack Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.36
Sales
$26.3M
Reporting Date
May 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 13.01%
 
 
 
 
 
 
Growthannually 27.82%
 
 
 
 
 
 

Sales

Growthquarterly 22.57%
 
 
 
 
 
 
Growthannually 94.27%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.